<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>GuosenHealthcare | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-10-28T23:26:09+08:00</updated>
  <subtitle>国信医药最新研究成果、行业深度资讯展示与交流平台，引领健康投资、健康生活新风尚！</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>【国信医药】迪安诊断：业绩超预期，实验室扭亏加速（三季报点评）</title>
    <updated>2020-10-28T12:24:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/t0WXSrVpmmkoHBtBMSvUBA</id>
    <link href="https://mp.weixin.qq.com/s/t0WXSrVpmmkoHBtBMSvUBA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】爱尔眼科：业绩超预期，眼科真龙头（三季报点评）</title>
    <updated>2020-10-28T12:24:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/eh5yoV_hcnhKLhQs26KOLQ</id>
    <link href="https://mp.weixin.qq.com/s/eh5yoV_hcnhKLhQs26KOLQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】贝达药业：埃克替尼稳健增长，业绩符合预期 （三季报点评）</title>
    <updated>2020-10-28T12:24:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/_SRRIipjYSU66ixHD1PksA</id>
    <link href="https://mp.weixin.qq.com/s/_SRRIipjYSU66ixHD1PksA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】长春高新：金赛稳健增长，疫苗快速放量（三季报点评）</title>
    <updated>2020-10-27T14:42:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-27:/s/f4tZ5F3nVilkXL23dx09Ng</id>
    <link href="https://mp.weixin.qq.com/s/f4tZ5F3nVilkXL23dx09Ng" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】凯莱英：业绩符合预期，维持高速增长（三季报点评）</title>
    <updated>2020-10-26T13:52:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-26:/s/V9j7YwHXi4IIweVElJf49A</id>
    <link href="https://mp.weixin.qq.com/s/V9j7YwHXi4IIweVElJf49A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】丽珠集团：收入高速增长，业绩符合预期（三季报点评）</title>
    <updated>2020-10-26T13:52:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-26:/s/hTEGfHbPKlsMISyt5j_03g</id>
    <link href="https://mp.weixin.qq.com/s/hTEGfHbPKlsMISyt5j_03g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】白马边际变化敏感，重磅药政变化临近（周观点）</title>
    <updated>2020-10-25T23:32:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-25:/s/k81prL0tjFgqACXSXA32bg</id>
    <link href="https://mp.weixin.qq.com/s/k81prL0tjFgqACXSXA32bg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】国药股份：疫情影响逐渐消退，精麻龙头现金流向好（三季报点评）</title>
    <updated>2020-10-25T23:32:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-25:/s/iyeioZSKJhN0Xwrc-Jj0WA</id>
    <link href="https://mp.weixin.qq.com/s/iyeioZSKJhN0Xwrc-Jj0WA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】佰仁医疗：疫情后快速恢复，瓣膜增长强劲（三季报点评）</title>
    <updated>2020-10-23T15:53:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-23:/s/d1mimz03jtoTsQiYciWGAA</id>
    <link href="https://mp.weixin.qq.com/s/d1mimz03jtoTsQiYciWGAA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】DRGs试点进一步扩大，把握三条投资主线（行业重大事件快评）</title>
    <updated>2020-10-21T17:11:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-21:/s/YCAtHANjUBGvG5u_OFK4GQ</id>
    <link href="https://mp.weixin.qq.com/s/YCAtHANjUBGvG5u_OFK4GQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】冠脉支架集采文件出台，不确定性即将出清（行业重大事件快评）</title>
    <updated>2020-10-19T19:00:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-19:/s/p5CQqX_57f9H0u9FthBrRQ</id>
    <link href="https://mp.weixin.qq.com/s/p5CQqX_57f9H0u9FthBrRQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】冠脉支架集采文件出台，关注新冠疫苗研发进展（周观点）</title>
    <updated>2020-10-18T21:25:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-18:/s/zR-b2ZOIHNb-LJhyRAdyJQ</id>
    <link href="https://mp.weixin.qq.com/s/zR-b2ZOIHNb-LJhyRAdyJQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】小分子药物发现技术平台：研发起点，新药之源（创新药盘点系列报告之十五）</title>
    <updated>2020-10-15T08:48:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-15:/s/-MiQuufM5OUPI108nf2R9w</id>
    <link href="https://mp.weixin.qq.com/s/-MiQuufM5OUPI108nf2R9w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】关注新冠疫苗和中和抗体临床进展（周观点）</title>
    <updated>2020-10-11T13:28:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-11:/s/MfstG9pjb_QuZK1UXbW8jA</id>
    <link href="https://mp.weixin.qq.com/s/MfstG9pjb_QuZK1UXbW8jA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>